tyra.bioHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $157.64MM
Tyra Biosciences targets resistance in oncology with purpose built drugs for the benefit of patients.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Tyra Biosciences.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.